Rarely, severe adverse effects can occur on stopping treatment with topical corticosteroids, often after long-term continuous or inappropriate use of moderate to high potency products. To reduce the risks of these events, pr…
Published: 2021-09-15T09:38:00Z
Recent information relating to COVID-19 vaccines and medicines that has been published since the August 2021 issue of Drug Safety Update, up to 9 September 2021.
Published: 2021-09-15T09:37:52Z
A summary of recent letters, medicine recalls and notifications sent to healthcare professionals
Published: 2021-09-15T09:37:43Z
Recent information relating to COVID-19 vaccines that has been published since the July 2021 issue of Drug Safety Update.
Published: 2021-08-16T13:04:56Z
A summary of recent letters, medicine recalls and notifications sent to healthcare professionals
Published: 2021-08-16T13:04:43Z
Following a review of the available toxicological data and a calculation of daily exposure to boron from a typical dosing regimen, we have concluded that the balance between the benefits and risks of chloramphenicol eye drop…
Published: 2021-07-07T16:13:51Z
If an adverse drug reaction is suspected, ask patients if they are taking any herbal or homeopathic medicines and report any suspicions to the Yellow Card scheme. Remind patients to check that a herbal or homeopathic medicin…
Published: 2021-07-07T16:13:40Z
We have published guidance about the use of remote consultations for pregnancy prevention in women of childbearing potential and monitoring for signs of psychiatric reactions (especially depression) and other safety risks in…
Published: 2021-07-07T16:13:31Z
Revisions have been made to the information for healthcare professionals and information for UK vaccine recipients for the COVID-19 Vaccine Moderna and Pfizer/BioNTech COVID-19 vaccine following a thorough review of ext…
Published: 2021-07-07T16:13:20Z
A summary of letters and drug alerts recently sent to healthcare professionals.
Published: 2021-07-07T16:13:08Z